D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+3.38%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$44.3B
AUM Growth
+$880M
Cap. Flow
-$1.29B
Cap. Flow %
-2.91%
Top 10 Hldgs %
11.39%
Holding
2,836
New
310
Increased
1,094
Reduced
999
Closed
312

Sector Composition

1 Technology 14.04%
2 Healthcare 13.47%
3 Financials 11.87%
4 Consumer Discretionary 10.86%
5 Industrials 10.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CFMS
2351
DELISTED
Conformis, Inc. Common Stock
CFMS
$144K ﹤0.01%
+709
New +$144K
VIPS icon
2352
Vipshop
VIPS
$8.85B
$142K ﹤0.01%
12,873
-12,927
-50% -$143K
WK icon
2353
Workiva
WK
$4.24B
$142K ﹤0.01%
+10,417
New +$142K
VALE icon
2354
Vale
VALE
$44.8B
$141K ﹤0.01%
18,502
-65,097
-78% -$496K
RGLS
2355
DELISTED
Regulus Therapeutics
RGLS
$139K ﹤0.01%
516
+42
+9% +$11.3K
ARNA
2356
DELISTED
Arena Pharmaceuticals Inc
ARNA
$138K ﹤0.01%
9,742
+7,722
+382% +$109K
CETV
2357
DELISTED
Central European Media Enterprises Ltd
CETV
$136K ﹤0.01%
53,244
+879
+2% +$2.25K
GERN icon
2358
Geron
GERN
$823M
$134K ﹤0.01%
64,499
-1,608
-2% -$3.34K
STGW icon
2359
Stagwell
STGW
$1.39B
$134K ﹤0.01%
20,400
-45,118
-69% -$296K
SRRA
2360
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$134K ﹤0.01%
2,248
+1,406
+167% +$83.8K
TOVX icon
2361
Theriva Biologics
TOVX
$3.95M
$133K ﹤0.01%
+20
New +$133K
GNMK
2362
DELISTED
GenMark Diagnostics, Inc
GNMK
$125K ﹤0.01%
+10,217
New +$125K
SCWX
2363
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$122K ﹤0.01%
+11,546
New +$122K
FCH
2364
DELISTED
Felcor Lodging Trust
FCH
$119K ﹤0.01%
14,842
-49,329
-77% -$396K
CCIH
2365
DELISTED
Chinacache International Holdings Ltd
CCIH
$118K ﹤0.01%
45,986
-4,722
-9% -$12.1K
TRVN
2366
DELISTED
Trevena, Inc.
TRVN
$116K ﹤0.01%
32
-10
-24% -$36.3K
ARCT icon
2367
Arcturus Therapeutics
ARCT
$489M
$114K ﹤0.01%
7,752
+3,098
+67% +$45.6K
LAYN
2368
DELISTED
Layne Christensen Co
LAYN
$110K ﹤0.01%
+10,088
New +$110K
PACB icon
2369
Pacific Biosciences
PACB
$366M
$108K ﹤0.01%
28,372
-113,196
-80% -$431K
SGY
2370
DELISTED
Stone Energy
SGY
$108K ﹤0.01%
+2,648
New +$108K
SQBG
2371
DELISTED
Sequential Brands Group, Inc.
SQBG
$107K ﹤0.01%
572
+180
+46% +$33.7K
TTNP icon
2372
Titan Pharmaceuticals
TTNP
$5.92M
$106K ﹤0.01%
7
PLUG icon
2373
Plug Power
PLUG
$1.66B
$105K ﹤0.01%
+87,111
New +$105K
AGTC
2374
DELISTED
Applied Genetic Technologies Corporation
AGTC
$104K ﹤0.01%
11,085
-1,012
-8% -$9.5K
IOVA icon
2375
Iovance Biotherapeutics
IOVA
$861M
$103K ﹤0.01%
+14,778
New +$103K